Very few countries allow direct-to-consumer pharmaceutical advertising. Pharmaceutical companies are able to advertise products on television, radio, streamed subscription services, etc. The Food and Drug Administration (FDA) has provided regulation to this communication in the United States. However, some believe that the regulations are not strict enough and/or not being followed. Some have a concern that these advertisements may not benefit consumers. They may also increase costs of medications. Nurse practitioners are often asked to give professional opinions regarding health care issues, including policies/laws that are being discussed.
For this discussion paper, please address the following questions:
-What are the FDA regulations regarding direct-to-consumer pharmaceutical advertising? (20 points)
-How prevalent is the direct-to-consumer pharmaceutical advertising in the United States? What are the statistical trends? Are there certain consumers who are targeted? Are there certain type of medications advertisements that are more prevalent than others? Is there evidence that the pharmaceutical companies are violating the FDA regulations?
-What are the benefits of direct-to-consumer pharmaceutical advertising?
-What are the risks and/or costs of direct-to-consumer pharmaceutical advertising? (15 points)
-What would be your professional recommendation regarding the policies and regulation of direct-to-consumer pharmaceutical advertising? Would you recommend it be eliminated in the United States? Would you recommend more regulation? Would you recommend less regulation? Do you feel the level of regulation is satisfactory, and should stay the same? Explain your recommendations thoroughly with evidence to support your opinions.
Last Completed Projects
| topic title | academic level | Writer | delivered |
|---|